MEDVi vs Noom Med: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent researchHow we rank →

MEDVi beats Noom Med overall, scoring 7.7/10 vs 7.4/10. Noom Med is more affordable at $99/mo vs $179/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Noom Med for users who want a tiered entry into glp-1 care, from $99/mo m.

A side-by-side look at MEDVi and Noom Med to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for
Higher Rated

MEDVi

#20 of 52
7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Noom Med

#27 of 52
7.4/10

Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med
FeatureMEDViNoom Med
Our Score7.7/107.4/10
Starting Price$179/mo$99/mo
Medication TypeBothBoth
Insurance AcceptedNoYes
Best ForUsers who want a low entry price with oral and injectable compounded optionsUsers who want a tiered entry into GLP-1 care, from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program
Ranking#20#27
Get startedVisit MEDViVisit Noom Med

Pros & Cons Compared

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
  • +Sleek onboarding experience with clear progress tracking through their patient portal
  • +$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

  • No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
  • No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Noom Med

Pros

  • +Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
  • +New Microdose GLP-1Rx program ($99-149/mo), low-dose GLP-1 + biomarker monitoring for sensitive users
  • +Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
  • +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

  • Tiered pricing creates confusion, $69, $99-149, or $149-349 depending on tier
  • Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
  • Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
  • App coaching still requires real engagement, skip-prone users waste the behavioral value

Our Verdict

MEDVi edges out Noom Med with a score of 7.7/10 vs 7.4/10. If budget is your priority, Noom Med starts at $99/mo compared to MEDVi's $179/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Noom Med if you want: users who want a tiered entry into glp-1 care, from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither MEDVi nor Noom Med feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Try MEDVi

Starting at $179/mo

Visit MEDVi

Try Noom Med

Starting at $99/mo

Visit Noom Med

Related comparisons

Other matchups readers comparing MEDVi or Noom Med tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

Yucca Health

7.7/10
$146/mo·Compounded

TrimRx

7.8/10
$149/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

SkinnyRx

7.3/10
$199/mo·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.